Tutorials
F-star Therapeutics Inc logo

F-star Therapeutics Inc

$ 6.57 -0.05 (-0.76%) 11:08 PM EST
P/E:
At Loss
P/B:
1.59
Market Cap:
$ 141.81M
Enterprise V:
$ 87.14M
Volume:
122.82K
Avg Vol (2M):
482.19K
Also Trade In:
Volume:
122.82K
Market Cap $:
141.81M
PE Ratio:
At Loss
Avg Vol (2-Month):
482.19K
Enterprise Value $:
87.14M
PB Ratio:
1.59
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

F-star Therapeutics Inc
NAICS : 325412 SIC : 2834
Babraham Research Campus, Eddeva B920, Cambridge, GBR, CB22 3AT
Description
F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments.
Name Current Vs Industry Vs History
Cash-To-Debt 5.27
Equity-to-Asset 0.77
Debt-to-Equity 0.15
Debt-to-EBITDA -0.42
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 2.01
Distress
Grey
Safe
Beneish M-Score -2.83
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 60.79
9-Day RSI 69.74
14-Day RSI 72.71
6-1 Month Momentum % 82.89
12-1 Month Momentum % -6.2

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 6.11
Quick Ratio 6.11
Cash Ratio 5.44
Days Sales Outstanding 49.11

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-08-12 Est.)

FSTX's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:FSTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 20.801
EPS (TTM) ($) -1.54
Beta 0
Volatility % 131.22
14-Day RSI 72.71
14-Day ATR ($) 0.177063
20-Day SMA ($) 6.364
12-1 Month Momentum % -6.2
52-Week Range ($) 2.07 - 8.36
Shares Outstanding (Mil) 21.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

F-star Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More